312
Participants
Start Date
March 25, 2022
Primary Completion Date
June 28, 2023
Study Completion Date
August 26, 2023
Text Message
Participants will be randomized to receive or not receive a text message encouraging COVID-19 vaccine uptake.
Motivational Interviewing
Participants will be randomized to receive either motivational interviewing when receiving SARS-CoV-2 antibody test results or standard interpretation of antibody results.
Electronic Educational Message with Tailored Questions/Prompts
Participants will be randomized to receive either an electronic educational message tailored to their COVID-19 vaccine concerns and vaccine status or an attention control message about overall healthy choices.
Oklahoma Clinical and Translational Science Institute, Oklahoma City
National Institutes of Health (NIH)
NIH
National Institute of General Medical Sciences (NIGMS)
NIH
University of Oklahoma
OTHER